Glaxo Singled Out in China Probe, Smith Says
July 24 (Bloomberg) -- Andy Smith, chief investment officer at Mann Bioinvest Ltd., talks about the Chinese probe of GlaxoSmithKline Plc over allegations of bribery and corruption. He speaks with Mark Barton and Anna Edwards on Bloomberg Television's "Countdown." (Source: Bloomberg)
Most Recent Videos
Was the DNC Hack Preventable?
51:38 - Eric O'Neill, Carbon Black's national security strategist, discusses how to respond to government hacks with Bloomberg's Emily Chang on "Bloomberg West." (Source: Bloomberg)